|
||
|
Yang, G-Y., Liao, J., Li, C., Chung, J.Y., Yurkow, E.J., Ho, C-T., and Yang, C.S. Effect of black and green tea polyphenols on c-jun phosphorylation and H 2O 2 production in transformed and non-transformed human bronchial cell lines: Possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis, 21: 2035-2039, 2000. Kim, S., Lee, M-J., Hong, J., Li, C., Smith, T.J., Yang, G-Y., Seril, D.N., and Yang, C.S. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr. Cancer, 37:41-48, 2000. Lee, M-J., Prabhu, S., Meng, X., Li, C., and Yang, C.S. An improved method for the determination of green and black tea polyphenols in biomatrices by high performance liquid chromatography with coulometric array detection. Anal. Biochem., 279:164-169 , 2000. Li, C., Lee, M-J., Sheng, S., Prabhu, S., Winnik, B., Huang, B., Meng, X., Chung, J.Y., Yan, S., Ho, C-T., and Yang, C.S. Structural identification and characterization of two metabolites of catechins in human urine and blood after tea ingestion. Chem. Res. Toxicol., 13:177-184 , 2000. Chung, J.Y., Huang, C., Meng, X., Dong, Z., and Yang, C.S. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res., 59:4610-4617 , 1999. August, D.A., Landau, J., Caputo, D., Hong, J., Lee, M-J., and Yang, C.S. Ingestion of green tea rapidly decreases prostaglandin E 2 levels in rectal mucosa in humans. Cancer Epidemiol. Biomark. Prev., 8:709-713 , 1999. Yang, C.S., Lee, M-J., and Chen, L. Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies. Cancer Epidemiol. Biomark. Prev., 8:83-89, 1999. Yang, C.S., Chen, L., Lee, M-J., Balentine, D., Kuo, M.C., and Schantz, S.P. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev., 7:351-354, 1998. Yang, G-Y., Liao, J., Kim, K., Yurkow, E.J., and Yang, C.S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis, 19:611-616, 1998. Landau, J.M., Wang, Z-Y., Yang, G-Y., Ding, W., and Yang, C.S. Inhibition of spontaneous formation of lung tumors and rhabdomyosarcomas in A/J mice by black and green tea. Carcinogenesis, 19:501-507, 1997. Yang, G-Y., Liu, Z., Seril, D.N., Liao, J., Ding, W., Kim, S., Bondoc, F., and Yang, C.S. Black tea constituents, theaflavins, inhibit 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice. Carcinogenesis, 18:2361-2365, 1997. Chen, L., Lee, M-J., Li, H., and Yang, C.S. Absorption, distribution, and elimination of tea polyphenols in rats. Drug Metab. Dispos., 25:1045-1050, 1997. Yang, C.S. Inhibition of carcinogenesis by tea. Nature 389:134-135, 1997. Yang, G-Y., Wang, Z-Y., Kim, S., Liao, J., Seril, D., Chen, X., Smith, T.J., and Yang, C.S. Characterization of early pulmonary hyperproliferation, tumor progression, and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis model with A/J mice. Cancer Res., 57:1889-1894, 1997. Wang, Z-Y., Wang, L-D., Lee, M-J., Ho, C-T., Huang, M-T., Conney A.H., and Yang, C.S. Inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats by green and black tea. Carcinogenesis, 16:2143-2148, 1995. Lee, M-J., Wang, Z-Y., Li, H., Chen, L., Sun, Y., Gobbo, S., Balentine, D.A., and Yang, C.S. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomark. Prev., 4:393-399, 1995. Wang, Z-Y., Huang, M-T., Lou, Y-R., Xie, J-G., Reuhl, K.R., Newmark, H.L., Ho, C-T., Yang, C.S., and Conney, A.H. Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. Cancer Res., 54:3428-3435, 1994. Yang, C.S. and Wang, Z-Y. Tea and Cancer: A review. J. Natl. Cancer Inst. (Invited Review), 85:1038-1049, 1993. |
|
Hurwitz, S.J., Coleman, C.N., Riese, N., Loeffler, J.S. Alexander, E., Buswell, L., Neben, T., Shargel, L., & Kramer, R.A., 1992. R.A. Distribution of etanidazole into human brain tumors: Implications for treating high grade gliomas. Int. J. Rad. Oncol., Biol. Phys., 22:573-576. Coleman, C.N., Noll, L., Riese, N., Buswell, L., Howes, A.E., Loeffler, J.S., Alexander, E. (III), Wen, P., Harris, J.R., Kramer, R.A., Hurwitz, S.J., Neben, T.Y., & Grigsby, P., 1992. Final report of the phase I trial of continuous infusion etanidazole (SR 2508)- a Rad. Ther. Oncol. Group study. Int. J. Rad. Oncol., Biol. Phys. 22:577-580. Malaker, K., Hurwitz, S.J., Riese, N., Bump, E.A., Griffith, O.W., & Coleman, C.N., 1994. Pharmacodynamics of glatathione depletion by continuous infusion L-buthionine S-sulphoximine . Int. J. Rad. Oncol., Biol. Phys., 29:407-412. Shulman, L.N., Buswell, L., Goodman, H., Muto, M., Berkowitz, R., Teicher, B., Kusumoto, T., Hurwitz, S.J., Kalish, L., & Coleman, C.N., 1994. Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancer. Int. J. Rad. Oncol., Biol. Phys., 29:545-548. Rubin, E., Wood, V., Bharti, A., Trites, D., Lynch, C., Hurwitz, S.J., Bartel, S., Levy, S., Rosowsky, A., Toppmeyer, D., & Kufe, D.W., 1995. A phase I and pharmacokinetic study of a new camptothecin derivative, 9-aminocamptothecin. Clin. Cancer Res. 1:269-276. Eder , J.P., Rubin, E., Stone, R., Bryant, M., Xu, G., Supko, J., Kinchla, N., Lynch, T., Hurwitz, S.J., Rodriguez, D, Shapiro, C., Toppmeyer, D., Grossband, M., Vosburg, E, Huberman, M., Schnippere, L., Shulman, L., & Kufe, D.W., 1996. Trials of 9-Amino-20(S)-camptothecin in Boston. Annals of NY. Acad. Sci., 803:247-255. Palayoor, S.T., Bump, E.A., Saroff, D.M., Delfs, J.R., Geula, C., Menton-Brennan, L., Hurwitz, S.J., & Coleman, C.N., 1996. Effect of BSO and etanidazole on neurofilament degradation in neonatal rat spinal cord cultures. Br. J. Cancer 74:S117-S121. Hurwitz, S.J., Terashima, M., Mizunuma, N., & Slapak, C.A., 1997. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes. Blood, 89:3745-3754 . Hurwitz, S.J., Tennant, B.C., Korba, B.E., & Schinazi, R. F., 1998. Pharmacodynamics of (-)- b - 2',3'-dideoxy-3'-thiacytidine (3TC) in chronically virus-infected woodchucks compared to its pharmacodynamics in humans . Antimicrob. Agents Chemother. 42:2804-2809. Ma, L., Hurwitz, S.J., Shi, J., Liotta, D.C., McClure, H.M., & Schinazi, R.F., 1999. Pharmacokinetics of b - D-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys. Antimicrob. Agents Chemother. 43:381-384. Mourier , N.S. , Eleuteri, A., Hurwitz, S.J., & Schinazi, R.F., 1999. Enantioselective synthesis and biological evaluation of new 5-o-carboranyl pyrimidine nucleosides. Bio-org. Med. Chem. 7:2759-2766. Hurwitz, S.J., Ma, L., Wright, J., Eleuteri, A., Moravek, J., & Schinazi, R.F., 2000. Cellular pharmacology of D and L-enantiomers of 5-carboranyl-2'-deoxyuridine. Nucleosides, Nucleotides & Nucleic acids 19:691-702. Schinazi, R.F, Hurwitz, S.J., Liberman, I., Juodawlkis, A., Shi, J., Liotta, D.C., Coderre, J., & Olson, J., 2000. Treatment of 9L gliosarcoma isografts with b -5-o-carboranyl-2'-deoxyuridine neutron capture therapy. Clin. Cancer Res. 6:725-730. Sun S-Y, Yue P, Hong WK, Lotan R. Augmentation of TRAIL-induced apoptosis through upregulation of death receptors by the synthetic retinoid CD437 in human lung cancer cells. Cancer Res, 60: 7149-7155, 2000. Sun S-Y, Yue P, Hong WK, Lotan R. Induction of Fas expression and augmentation of Fas/FasL-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells. Cancer Res 60: 6537-6543, 2000. Sun S-Y, Yue P, Chandraratna RAS, Tesfaigzi Y, Hong WK, Lotan R. Dual mechanisms of action of the retinoid CD437: nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells. Mol Pharmacol 58:508-514, 2000. Sun S-Y, Li W, Yue P, Hong WK, Lotan R. Mediation of 4-(N-hydroxyphenyl) retinamide (4-HPR)-induced apoptosis in human cancer cells by different mechanisms. Cancer Res 59: 2493-2498, 1999. Sun S-Y, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, Heyman RA, Chandraratna RAS, Shudo K, Hong WK, Lotan R. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Clin Cancer Res 6: 1563-1573, 2000. Stewart MG, Chen AY, Stach C. Outcomes analysis of voice and quality of life in laryngeal cancer patients. Arch Otolaryngol Head Neck Surg. 1998;124(2): 143-148. Chen, AY , Callender DL, Mansyur C, Reyna KM, Limitone E, Goepfert H. The impact of clinical pathways on the practice of head and neck oncologic surgery: The University of Texas M. D. Anderson Cancer Center Experience. Arch Otolaryngol Head Neck Surg, 2000;126:322-326. Chen AY, Myers, JN. Cancer of the oral cavity. Current Problems in Surgery 2000;37(10):633-672.
|
||
| Last update: June 21st, 2007 by Robert Fu & Edwin Shin |
||